medigraphic.com
Asociación Mexicana de Gastroenterología

2007, Number 4

<< Back Next >>

Rev Gastroenterol Mex 2007; 72 (4)

Effect of Helicobacter pylori infection on gastric ghrelin expression and body weight

Méndez-Sánchez N, Pichardo-Bahena R, Vásquez-Fernández F, Lezama-Mora JI, León-Canales AL, Barredo-Prieto B, González-Avila D, Ponciano-Rodríguez G, Uribe M

Language: English
References: 30
Page: 359-364
PDF size: 56.27 Kb.


ABSTRACT

Background & Aim: Ghrelin is a peptide mainly produced by gastric tissue playing an important role in energy homeostasis. It has been suggested that inflammatory and atrophic events induced by Helicobacter pylori (H. pylori) infection in gastric mucosa compromise the survival of the ghrelin-producing cells. The aim of this study was to investigate the effect of H. pylori infection on gastric ghrelin expression and body weight. Methods: Consecutive patients referred for upper endoscopy were invited to participate. Patients with H. pylori infection (determined by histology) were defined as cases and patients without infection as controls. The density of colonization was classified in mild, moderate, or severe infection. Body mass index (BMI) was calculated. Ghrelin-immunoreactive cells were quantified in gastric biopsies by immunohistochemical staining. Results: We studied 189 cases (92 males, 97 females) and 94 controls (55 males, 39 females). Cases were older (48.16 ± 16.44 vs. 42.88 ± 17.04 years, p ‹ 0.05) and exhibited a lower percentage of ghrelin-immunoreactive cells (2.13% vs. 10.43%, p ‹ 0.05) than controls. The prevalence of obesity was significantly lower than normal-weight among all cases, independently of the severity of infection (mild infection, 17.6% vs. 47.3%, p = 0.001; moderate-severe infection, 10.4% vs. 50%, p = 0.001). Univariate analysis showed a non-significant trend suggesting a protective effect of H. pylori against obesity. Nevertheless, BMI did not differ significantly between cases and controls. Conclusion: Chronic H. pylori infection contributes to a lower percentage of gastric ghrelin-immunoreactive cells but has no effect on the body weight of infected patients.


REFERENCES

  1. Villa AR, Escobedo MH, Méndez-Sánchez N. Estimates and trends of obesity prevalence through mortality rates associated of chronic diseases in Mexico. Gac Med Mex 2004; 140(Suppl. 2): S21-S5.

  2. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, Morelos, Mexico.

  3. Cummings DE, Schwartz MW. Genetic and pathophysiology of human obesity. Annu Rev Med 2003; 54: 453-71.

  4. St-Pierre DH, Wang L, Tache Y. Ghrelin: a novel player in the gut-brain regulation of growth hormone and energy imbalance. News Physiol Sci 2003; 18: 242-6.

  5. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-60.

  6. Tomasetto C, Karam SM, Ribieras S, Masson R, Lefebvre O, Staub A, et al. Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide. Gastroenterology 2000; 119: 295-405.

  7. Méndez-Sánchez N, Chávez-Tapia NC, Uribe M. Ghrelin and the gastro-hypothalamic axis. Gac Med Mex 2006; 142: 49-58.

  8. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, et al. Ghrelin, a novel growth hormone – releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141: 4255-61.

  9. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosada K, Akamizu T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001; 86: 4753-8.

  10. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992-5.

  11. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. Am J Surg Pathol 1996; 20: 1161-81.

  12. O’Connor H, Sebastian S. The burden of helicobacter pylori infection in Europe. Aliment Pharmacol Ther 2003; 18(Suppl. 3): 38-44.

  13. Graham DY, Adam E, Reddy GT, Agarwal JP, Agarwal R, Evans DJ, et al. Seroepidemiology of Helicobacter pylori infection in India. Dig Dis Sci 1991; 36: 1084-8.

  14. Holcombe C, Omotara BA, Eldrige J, Jones DM. H. pylori, the most common bacterial infection in Africa: a random serological study. Am J Gastroenterol 1992; 87: 28-30.

  15. Mitchell HM. The epidemiology of Helicobacter pylori. Curr Top Microbiol Immunol 1999; 241: 11-30.

  16. Graham DY, Malaty HM, Evans DG, Evans DJ, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991; 100: 1495-501.

  17. Brown LM. Helicobacter pylori: Epidemiology and routes of transmission. Epidemiol Rev 2000; 22: 283-97.

  18. Isomoto H, Nakazato M, Ueno H, Date Y, Nishi Y, Mukae H, et al. Low Plasma Ghrelin Levels in Patients with Helicobacter pylori – Associated Gastritis. Am J Med 2004; 117: 429-32.

  19. Talamini G, Zamboni G, Cavallini G. Antral mucosal Helicobacter pylori infection density as a risk factor of duodenal ulcer. Digestion 1997; 58: 211-7.

  20. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, et al. A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-8.

  21. Nwokolo CU, Freshwater DA, O’Hare P, Randeva HS. Plasma ghrelin following cure of Helicobacter pylori. Gut 2003; 52: 637-40.

  22. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000; 141: 4325-8.

  23. Tschöp M, Weyer C, Tataranni PA, Devanarayan E, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707-9.

  24. Isomoto H, Ueno H, Saenko VA, Mondal MS, Nishi Y, Kawano N, et al. Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans. Am J Gastroenterol 2005; 100: 1711-20.

  25. Tatsuguchi A, Mikaye K, Gudis K, Futagami S, Tsukui T, Wada K, et al. Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa. Am J Gastroenterol 2004; 99: 2121-7.

  26. Osawa H, Kita H, Ohnishi H, Nakazato M, Date Y, Bowlus CL, et al. Changes in plasma ghrelin levels, gastric ghrelin production, and body weight after Helicobacter pylori cure. J Gastroenterol 2006; 41: 954-61.

  27. Grgov S, Stefanovie M, Katie V. The relationship between the density of Helicobacter pylori colonization and the degree of gastritis severity. Arch Gastroenterolhepatol 2002; 21: 3-4.

  28. Liew PL, Lee WJ, Lee YC, Chen WY. Gastric ghrelin expression associated with Helicobacter pylori infection and chronic gastritis in obese patients. Obese Surg 2006; 16: 612-9.

  29. Olaiz-Fernández G, Rojas R, Barquera S. Encuesta Nacional de Salud 2000. Cuernavaca, Morelos, México

  30. Suzuki H, Masaoka T, Hosada H, Ota T, Minegishi Y, Nomura S, et al. Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut 2004; 53: 187-94.




2020     |     www.medigraphic.com